Category: Regulations
-
Precision Medicine Trial Shows Reduced Pain, Opioid Use
A large-scale clinical trial tracking pain treatments guided by genetic testing shows large majorities of participants report less pain, with fewer individuals using opioid drugs.
-
Fixed-Dose Blood Pressure Drugs Shown Cost-Effective
An analysis of medical insurance claims shows fixed-dose combination drugs to be the most cost-effective medication strategy for people with hypertension, or high blood pressure.
-
Bacteria Traffic Tracked in New Hospital
The opening of a new hospital in Chicago offered an opportunity to follow the formation of bacterial communities and their movement in a health care facility.
-
Trial Begins of Freeze-Dried Blood Plasma
A clinical trial is underway testing the safety and practicality of using a person’s own freeze-dried blood plasma for transfusions, substituting for frozen or liquid plasma.
-
Trial to Test Spherical Nanotech Brain Cancer Drug
An early-stage clinical trial will soon begin testing spherically-shaped nanoscale particles to treat glioblastoma, an aggressive form of brain cancer.
-
Growing Engineered Algae Outdoors Shown Feasible, Safe
A test of cultivating genetically engineered algae in outdoor tanks shows the production technique is feasible and does not pose risks to native algae populations.
-
Muscle Supplement Shown Safe, Active in Elderly
A clinical trial testing a dietary supplement to improve muscle function in older persons shows the derivative from pomegranates is safe and produces desired biological actions.
-
FDA Warns Cancer Fraud Product Providers
The Food and Drug Administration sent warning letters to 14 companies in the U.S. that the agency says are selling products fraudulently claiming to prevent, diagnose, treat, or cure cancer.
-
Research, Medical Groups Join Science March
A collection of 25 organizations representing a range of medical research and practice disciplines announced their participation in the March for Science set for Saturday, 22 April.
-
Factors IDed Boosting Post-Surgical Opioid Risk
An analysis of insurance claims identifies risk factors behind a sizeable number of people undergoing surgery becoming persistent users of opioid pain drugs long after their procedures.